Severity, criticality, and fatality of the SARS-CoV-2 Beta variant. Academic Article uri icon

Overview

abstract

  • Beta (B.1.351) variant COVID-19 disease was investigated in Qatar. Compared to Alpha (B.1.1.7) variant, odds of progressing to severe disease were 1.24-fold (95% CI: 1.11-1.39) higher for Beta. Odds of progressing to critical disease were 1.49-fold (95% CI: 1.13-1.97) higher. Odds of COVID-19 death were 1.57-fold (95% CI: 1.03-2.43) higher.

authors

  • Abu-Raddad, Laith Jamal
  • Chemaitelly, Hiam Souheil
  • Ayoub, Houssein H
  • Yassine, Hadi M
  • Benslimane, Fatiha M
  • Al Khatib, Hebah A
  • Tang, Patrick
  • Hasan, Mohammad R
  • Coyle, Peter
  • AlMukdad, Sawsan
  • Al Kanaani, Zaina
  • Al Kuwari, Einas
  • Jeremijenko, Andrew
  • Kaleeckal, Anvar Hassan
  • Latif, Ali Nizar
  • Shaik, Riyazuddin Mohammad
  • Abdul Rahim, Hanan F
  • Nasrallah, Gheyath K
  • Al Kuwari, Mohamed Ghaith
  • Butt, Adeel A
  • Al Romaihi, Hamad Eid
  • Al-Thani, Mohamed H
  • Al Khal, Abdullatif
  • Bertollini, Roberto

publication date

  • October 17, 2021

Research

keywords

  • COVID-19
  • SARS-CoV-2

Identity

Digital Object Identifier (DOI)

  • 10.1093/cid/ciab909

PubMed ID

  • 34657152